A new evidence-based guideline for assessment and management of polycystic ovary syndrome

Robert J Norman and Helena J Teede
Med J Aust 2018; 209 (7): . || doi: 10.5694/mja18.00635
Published online: 1 October 2018

An Australian-led international and multidisciplinary collaboration has developed new recommendations to improve the care, health outcomes and quality of life of women with PCOS

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions in women of reproductive age and often presents in adolescence with further manifestation in later reproductive life.1 Many women are not diagnosed or have long delays before the condition is recognised.2 Key patient needs are not being met well, and knowledge gaps have been shown in both patients and health professionals alike.2,3 This is of particular concern in a condition where the prevalence is generally considered to be between 9% and 18%, depending on the definition and the population studied.4

  • Robert J Norman1,2
  • Helena J Teede3

  • 1 Robinson Research Institute, University of Adelaide, Adelaide, SA
  • 2 Fertility SA, Adelaide, SA
  • 3 Monash Partners Academic Health Sciences Centre, Monash University, Melbourne, VIC


The Centre of Research Excellence in PCOS is funded by the National Health and Medical Research Council.

Competing interests:

We are co-authors of the International evidence-based guideline for the assessment and management of polycystic ovary syndrome.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.